Evidence Hub

Endoscopic and Symptomatic Outcomes of Vonoprazan for Erosive Esophagitis Following Laparoscopic Sleeve Gastrectomy: An Exploratory Prospective Study

Hideharu Okanobu, Kazuki Boda, Akihiro Sakai, Toshitsune Ikeda, Ryo Yuge, Nami Mori, Makoto Kobayakawa, Takenori Okada et al.

Internal Medicine, 2026

54 participants

Abstract

Background Gastroesophageal reflux disease (GERD) commonly occurs or worsens after laparoscopic sleeve gastrectomy (LSG); however, evidence regarding optimal medical management remains limited. This prospective study evaluated the endoscopic and symptomatic outcomes of Vonoprazan (VPZ), a potassium-competitive acid blocker, in erosive esophagitis (EE) following LSG.Methods Among 54 consecutive patients who underwent LSG, 19 who developed GERD symptoms within one year were included in the analysis. At symptom onset, esophagogastroduodenoscopy (EGD) was promptly performed to assess EE according to the Los Angeles (LA) classification, and the Frequency Scale for the Symptoms of GERD (FSSG) questionnaire was administered. All symptomatic patients were treated with VPZ (20 mg once daily for 4 weeks), after which EGD and FSSG assessments were repeated to evaluate therapeutic efficacy.Results Of the 19 patients, 16 (84.2%) had EE (LA grades A/B/C: 4/7/5), and 3 had non-erosive reflux disease (NERD). Among the patients with EE, 11 had de novo cases, and no grade C esophagitis was present preoperatively. The median interval to symptom onset was 40 days (range, 2-196 days). After 4 weeks of VPZ, complete mucosal healing was confirmed in all patients with EE (100% healing rate). The median FSSG scores in the EE group significantly improved from 28 (14-45) to 7 (1-31) (p<0.001).Conclusion Short-term improvements in the endoscopic findings and symptoms were observed after 4 weeks of VPZ…

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 54 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free